Latest Communications

18 January 2012
APR Applied Pharma Research s.a. (“APR”), Labtec GmbH (“Labtec”) and Norgine BV (“Norgine”) announce the signature of an exclusive licensing agreement under which Norgine will market and distribute Setofilm™ Ondansetron Oral Dispersible Film (“ODF”), in Europe and selected non-European countries.

12 July 2011
MonoSol Rx Announces Availability of Zuplenz® Oral Soluble Film for Licensing to New Commercialization Partners

13 June 2011
APR Applied Pharma Research s.a. and Labtec GmbH announce Ondansetron Oral Dispersible Film (“ODF”) is now available for licensing in Europe and selected non European countries, after having received marketing authorization in most countries of Europe.


Pharma

Acne

Our patented Nano-Technology electrolytic process enables production of Pure and Stable HClO (Hypoclorous Acid) in a liquid carrier (Bio'n), where all the most important parameters are balanced and optimized in order to obtain one of the best formulation in terms of Efficacy and Safety so maximizing its disinfectant and tissue regenerating properties.


HClO is produced by human immune system as protective agent against infectious pathogens, including bacteria, viruses, yeasts and some fungi and it is also one of the primary driver in any tissue regeneration, wound healing process.


Bio'n is under investigation skin infections, the first tests on the Product showed much promising results.


Acne products

Bio'n for acne





Search results